Advertisement
| what medications require aims assessment: Drug Induced Movement Disorders Stewart Factor, Anthony Lang, William Weiner, 2008-04-15 The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist. |
| what medications require aims assessment: Managing the Side Effects of Psychotropic Medications, Second Edition Joseph F. Goldberg, M.D., M.S., Carrie L. Ernst, M.D., 2018-08-10 This book has been divided into three main sections. Part I deals with global issues that bear on the assessment and formulation of possible adverse effects and with pertinent concepts related to basic pharmacology, physiology, and medical monitoring. The chapters in Part II present information organized by individual organ systems or specific medical circumstances rather than by drugs or drug classes. This approach seems to provide a logical and comprehensible format that allow readers to search out information as referenced by a particular side effect (and its varied potential causes) and to locate a discussion of practical management strategies. Part III focuses on summary recommendations covering all the material presented in the book and is followed by helpful appendixes on self-assessment questions and resources for practitioners. The book is meant to serve as a ready reference that simultaneously provides scientific and scholarly discussion of available treatment options and presents their scientific rationales.--page xx. |
| what medications require aims assessment: The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia American Psychiatric Association, 2016 The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. |
| what medications require aims assessment: Encyclopedia of Movement Disorders , 2010-02-26 The Encyclopedia of Movement Disorders is a comprehensive reference work on movement disorders, encompassing a wide variety of topics in neurology, neurosurgery, psychiatry and pharmacology. This compilation will feature more than 300 focused entries, including sections on different disease states, pathophysiology, epidemiology, genetics, clinical presentation, diagnostic tools, as well as discussions on relevant basic science topics. This Encyclopedia is an essential addition to any collection, written to be accessible for both the clinical and non-clinical reader. Academic clinicians, translational researchers and basic scientists are brought together to connect experimental findings made in the laboratory to the clinical features, pathophysiology and treatment of movement disorders. The Encyclopedia targets a broad readership, ranging from students to general physicians, basic scientists and Movement Disorder specialists. Published both in print and via Elsevier’s online platform of Science Direct, this Encyclopedia will have the enhanced option of integrating traditional print with online multimedia. Connects experimental findings made in the laboratory to the clinical features, pathophysiology, and treatment of movement disorders Encompasses a wide variety of topics in neurology neurosurgery, psychiatry, and pharmacology Written for a broad readership ranging from students to general physicians, basic scientists, and movement disorder specialists |
| what medications require aims assessment: Pathophysiology, Pharmacology and Biochemistry of Dyskinesia Jonathan Brotchie, Erwan Bezard, Peter Jenner, 2011-09-19 Published since 1959, International Review of Neurobiology is a well-known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research. This volume reviews existing theories and current research surrounding the movement disorder Dyskinesia. Leading authors review state-of-the-art in their field of investigation and provide their views and perspectives for future research Chapters are extensively referenced to provide readers with a comprehensive list of resources on the topics covered All chapters include comprehensive background information and are written in a clear form that is also accessible to the non-specialist |
| what medications require aims assessment: Antipsychotic Drugs Thomas L. Schwartz, James Megna, Michael E. Topel, 2013 Since the mid-1990s, a revolution in regards to prescribing antipsychotics has taken place. Once utilized only for schizophrenia, the newer, second generation antipsychotics have now been approved for the treatment of bipolar disorders, depressive disorders, and autism spectrum disorders. They are often utilised elsewhere for the treatment of anxiety disorders, sleep disorders, and to calm agitated patients when dangerous behaviours occur. Prescription rates have soared making them some of the most advertised, prescribed and profitable drugs on the market. This book was developed with input of international authors of varying backgrounds to review the history and development of these agents and to focus on the utilization of these drugs in various disorders, age groups, and clinical situations. |
| what medications require aims assessment: Tardive Dyskinesia American Psychiatric Association. Task Force on Tardive Dyskinesia, 1992 Since the APA's last report on tardive dyskinesia in 1979, considerable research has been conducted on the prevalence, incidence, and risk factors associated with the development of late-occurring neuroleptic side effects. This book summarizes the progress made over the last decade in understanding the differential diagnosis and epidemiology of tardive dyskinesia, as well as risk factors, course, and treatment. The reader will benefit from the book's coverage of * indications for neuroleptic use* alternative maintenance strategies* factors to consider in making a differential diagnosis* frequently encountered problems in dealing with special populations such as children and mentally retarded people* clinical-legal issues related to tardive dyskinesia * clearly specified recommendations for prevention and management |
| what medications require aims assessment: Improving Healthcare Quality in Europe Characteristics, Effectiveness and Implementation of Different Strategies OECD, World Health Organization, 2019-10-17 This volume, developed by the Observatory together with OECD, provides an overall conceptual framework for understanding and applying strategies aimed at improving quality of care. Crucially, it summarizes available evidence on different quality strategies and provides recommendations for their implementation. This book is intended to help policy-makers to understand concepts of quality and to support them to evaluate single strategies and combinations of strategies. |
| what medications require aims assessment: Medication-Induced Movement Disorders Joseph H. Friedman, 2020-05-07 Medications that may produce movement disorders are widely used. The resulting disorders are often highly disconcerting for the patient and their relatives, especially when the connection between medication and disorder is not recognized. However, ascribing an adverse drug effect to medication exposure is often difficult, especially when the side effect is rare. Covering various drugs - including the major classes of medications working primarily on the brain, specifically antipsychotics and antidepressants - this all-encompassing review of medication-induced movement disorders aids early recognition and improved treatment. The problem of what to do when the offending medication cannot be reduced is also reviewed. It discusses the best options for evaluation and treatment, including medical imaging and deep brain stimulation, and guides the clinician in managing the disorder, making this a vital reference for medical specialists and consultants in neurology and neuropharmacology and any clinician seeing patients on medications crossing the blood brain barrier. |
| what medications require aims assessment: Unbroken Brain Maia Szalavitz, 2016-04-05 A NEW YORK TIMES BESTSELLER More people than ever before see themselves as addicted to, or recovering from, addiction, whether it be alcohol or drugs, prescription meds, sex, gambling, porn, or the internet. But despite the unprecedented attention, our understanding of addiction is trapped in unfounded 20th century ideas, addiction as a crime or as brain disease, and in equally outdated treatment. Challenging both the idea of the addict's broken brain and the notion of a simple addictive personality, The New York Times Bestseller, Unbroken Brain, offers a radical and groundbreaking new perspective, arguing that addictions are learning disorders and shows how seeing the condition this way can untangle our current debates over treatment, prevention and policy. Like autistic traits, addictive behaviors fall on a spectrum -- and they can be a normal response to an extreme situation. By illustrating what addiction is, and is not, the book illustrates how timing, history, family, peers, culture and chemicals come together to create both illness and recovery- and why there is no addictive personality or single treatment that works for all. Combining Maia Szalavitz's personal story with a distillation of more than 25 years of science and research,Unbroken Brain provides a paradigm-shifting approach to thinking about addiction. Her writings on radical addiction therapies have been featured in The Washington Post, Vice Magazine, The Wall Street Journal, and The New York Times, in addition to multiple other publications. She has been interviewed about her book on many radio shows including Fresh Air with Terry Gross and The Brian Lehrer show. |
| what medications require aims assessment: Psychosis and Schizophrenia in Children and Young People National Collaborating Centre for Mental Health (Great Britain), 2013 These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. There is a worse prognosis for psychosis and schizophrenia when onset is in childhood or adolescence, and this new NICE guideline puts much-needed emphasis on early recognition and assessment of possible psychotic symptoms. For the one-third of children and young people who go on to experience severe impairment as a result of psychosis or schizophrenia the guideline also offers comprehensive advice from assessment and treatment of the first episode through to promoting recovery.This guideline reviews the evidence for recognition and management of psychosis and schizophrenia in children and young people across the care pathway, encompassing access to and delivery of services, experience of care, recognition and management of at-risk mental states, psychological and pharmacological interventions, and improving cognition and enhancing engagement with education and employment. |
| what medications require aims assessment: Pediatric Brain Stimulation Adam Kirton, Donald L. Gilbert, 2016-05-04 Pediatric Brain Stimulation: Mapping and Modulating the Developing Brain presents the latest on this rapidly expanding field that has seen an exponential growth in publications over the past 10 years. Non-invasive modalities like TMS can painlessly map and measure complex neurophysiology in real patients. Neuromodulatory applications like rTMS and tDCS carry increasingly proven therapeutic applications. Rapidly advancing technological methodologies are increasing opportunities and indications. Despite all these benefits, applications in the more plastic developing brains of children are only just emerging. This book provides a comprehensive overview of brain stimulation in children. Chapters include Transcranial Magnetic Stimulation (TMS) fundamentals, brain stimulation in pediatric neurological conditions, and invasive brain stimulation. The main audience for this research will be those interested in applying brain stimulation technologies to advance clinical research and patient care, although a wide variety of clinicians and scientist will find this to be a valuable reference on brain stimulation with specific chapters on a variety of conditions. - Provides an overview of recent findings and knowledge of pediatric brain stimulation and the developing brain - Edited by renowned leaders in the field of pediatric brain stimulation - Presents a great resource for basic and clinical scientists and practitioners in neuroscience, neurology, neurosurgery, and psychiatry |
| what medications require aims assessment: Advances in Patient Safety Kerm Henriksen, 2005 v. 1. Research findings -- v. 2. Concepts and methodology -- v. 3. Implementation issues -- v. 4. Programs, tools and products. |
| what medications require aims assessment: Oxford Handbook of Prescribing for Nurses and Allied Health Professionals Sue Beckwith, Penny Franklin, 2011-05-12 This new edition is fully revised to provide concise, practical, and expert advice for the non-medical prescriber. Intended for all levels, it covers basic pharmacology, legal parameters, safe and effective prescribing and common conditions. Written by experienced nurse prescribers, it contains a wealth of guidance and information. |
| what medications require aims assessment: Practice Guideline for the Treatment of Patients with Schizophrenia American Psychiatric Association, 1997 The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. |
| what medications require aims assessment: Neuroleptic Malignant Syndrome and Related Conditions Stephan C. Mann, Stanley N. Caroff, Paul E. Keck, Arthur Lazarus, 2008-05-20 Neuroleptic malignant syndrome (NMS) and other hyperthermic conditions are rare complications of antipsychotic drugs that can cause discomfort, disability, and even death. As a result, every psychiatrist, physician, and mental health care professional needs to understand and identify these disorders in time to prevent a fatal outcome. Neuroleptic Malignant Syndrome and Related Conditions is an important tool for clinicians, outlining a framework for understanding, diagnosing, treating, and preventing these little-understood disorders. This new edition extensively updates and revises the first edition, integrating an explosion of findings that have occurred since the earlier edition was published in 1989. In addition to NMS, chapters focus on antipsychotic drug-related heatstroke, hyperthermia associated with other neuropsychiatric drugs, and malignant catatonia, as well as A new chapter on serotonin syndrome, the first comprehensive review to appear in the world literature. With the proliferation of serotonergic drugs such as Selective Serotonin Reuptake Inhibitors (SSRIs), the incidence of adverse reactions is on the rise, and this information will help practitioners spot early warning signals. Important information on thermoregulatory mechanisms to help clinicians understand the pathogenesis of hyperthermic conditions. With an understanding of the basic mechanisms underlying these conditions, practitioners will develop more effective strategies for recognition, diagnosis, and treatment. Written by four internationally renowned authorities on NMS, Neuroleptic Malignant Syndrome and Related Conditions is the most comprehensive resource on the subject in existence. With nearly 850 citations in the reference section, it is a must for researchers -- and for practitioners who need a practical approach based on the most current science. |
| what medications require aims assessment: Hyperkinetic Movement Disorders Alberto Albanese, Joseph Jankovic, 2012-03-07 Hyperkinetic movement disorders comprise a range of diseases characterized by unwanted and uncontrollable, or poorly controllable, involuntary movements. The phenomenology of these disorders is quite variable encompassing chorea, tremor, dystonia, myoclonus, tics, other dyskinesias, jerks and shakes. Discerning the underlying condition can be very difficult given the range and variability of symptoms. But recognizing the phenomenology and understanding the pathophysiology are essential to ensure appropriate treatment. Hyperkinetic Movement Disorders provides a clinical pathway for effective diagnosis and management of these disorders. The stellar international cast of authors distils the evidence so you can apply it into your practice. The judicious use of diagnostic criteria algorithms rating scales management guidelines Provides a robust framework for clear patient management. Throughout the text, QR codes* provide smartphone access to case-study videos of hyperkinetic symptoms. Purchase includes an enhanced Wiley Desktop Edition.* This is an interactive digital version featuring: all text and images in fully searchable form integrated videos of presentations View a sample video: www.wiley.com/go/albanese highlighting and note taking facilities book marking linking to additional references Hyperkinetic Movement Disorders provides you with the essential visual and practical tools you need to effectively diagnose and treat your patients. *Full instructions for using QR codes and for downloading your digital Wiley DeskTop Edition are inside the book. |
| what medications require aims assessment: The American Psychiatric Publishing Textbook of Psychopharmacology Alan F. Schatzberg, Charles B. Nemeroff, 2009 Now updated to keep professionals current with the latest research and trends in the field, this edition covers both basic science and clinical practice, and draws on the talents of 53 new contributors to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy. |
| what medications require aims assessment: Drug Interactions in Psychiatry Domenic A. Ciraulo, 2006 Thoroughly updated for its Third Edition, this handbook provides complete, current, and easily accessible information on how psychotropic drugs interact with one another and with compounds used to treat non-psychiatric medical conditions. The book is organized for rapid reference, includes numerous tables, and offers guidelines for managing adverse effects. The Third Edition includes an adverse drug effects table in the appendix section, tables on receptor binding and dosing, and the latest information on drugs of abuse and chemical dependence. This edition also includes drug-food interactions for each drug category and interactions of psychotropic drugs with HIV medications. |
| what medications require aims assessment: Handbook of Drug Administration via Enteral Feeding Tubes, 3rd edition Rebecca White, Vicky Bradnam, 2015-03-11 With over 400 drug monographs, this book covers the technical, practical and legal aspects that you should consider before prescribing or administering drugs via enteral feeding tubes. |
| what medications require aims assessment: Dyskinesia D.E. Casey, T.N. Chase, A.V. Christensen, J. Gerlach, 2013-03-12 Papers Presented at an International Symposium, Held in 1984 at Kollekolle, Denmark |
| what medications require aims assessment: Drugs, Brains, and Behavior , 2007 |
| what medications require aims assessment: The Maudsley Prescribing Guidelines in Psychiatry David M. Taylor, Thomas R. E. Barnes, Allan H. Young, 2018-07-16 The revised 13th edition of the essential reference for the prescribing of drugs for patients with mental health disorders The revised and updated 13th edition of The Maudsley Prescribing Guidelines in Psychiatry provides up-to-date information, expert guidance on prescribing practice in mental health, including drug choice, treatment of adverse effects and how to augment or switch medications. The text covers a wide range of topics including pharmacological interventions for schizophrenia, bipolar disorder, depression and anxiety, and many other less common conditions. There is advice on prescribing in children and adolescents, in substance misuse and in special patient groups. This world-renowned guide has been written in concise terms by an expert team of psychiatrists and specialist pharmacists. The Guidelines help with complex prescribing problems and include information on prescribing psychotropic medications outside their licensed indications as well as potential interactions with other medications and substances such as alcohol, tobacco and caffeine. In addition, each of the book’s 165 sections features a full reference list so that evidence on which guidance is based can be readily accessed. This important text: Is the world’s leading clinical resource for evidence-based prescribing in day-to-day clinical practice and for formulating prescribing policy Includes referenced information on topics such as transferring from one medication to another, prescribing psychotropic medications during pregnancy or breastfeeding, and treating patients with comorbid physical conditions, including impaired renal or hepatic function. Presents guidance on complex clinical problems that may not be encountered routinely Written for psychiatrists, neuropharmacologists, pharmacists and clinical psychologists as well as nurses and medical trainees, The Maudsley Prescribing Guidelines in Psychiatry are the established reference source for ensuring the safe and effective use of medications for patients presenting with mental health problems. |
| what medications require aims assessment: Movement Disorder Emergencies Steven J. Frucht, Stanley Fahn, 2008-02-10 Movement Disorder Emergencies: Diagnosis and Treatment provides a fresh and unique approach to what is already a high-profile subspecialty area in clinical neurology. The disorders covered in this volume are standard fare in the field but emphasize the urgencies and emergencies that can occur. One of the very attractive features of the field of movement disorders is that diagnosis is often based on unique visible and sometimes audible phenomenological symptoms and signs. Therefore, in this era of highly sophisticated laboratory and radiological diagnostic tools, the diagnosis of many movement disorders is still largely made in the clinic where pattern recognition is key. Crucial to astute clinical diagnosis is broad clinical experience. In short, you have to have seen one to recognize one! Patients with movement disorders nearly always present as outpatients but, as aptly recognized by Drs. Frucht and Fahn, this may include acute manifestations leading to emergency presentations, often in an emergency room setting, where they are very likely to be unrecognized and therefore poorly managed. The authors define an “emergency” movement disorder as one in which failure to promptly diagnose and treat may result in significant morbidity or mortality. However, they also stress the importance of certain “can’t miss” diagnoses such as Wilson’s disease, dopa-responsive dystonia, and Whipple’s disease in which delayed diagnosis in less emergent situations can lead to slowly evolving and often irreversible neurological damage with tragic consequences. |
| what medications require aims assessment: Principles and Practice of Movement Disorders E-Book Joseph Jankovic, Mark Hallett, Stanley Fahn, 2011-08-09 Principles and Practice of Movement Disorders provides the complete, expert guidance you need to diagnose and manage these challenging conditions. Drs. Stanley Fahn, Joseph Jankovic and Mark Hallett explore all facets of these disorders, including the latest rating scales for clinical research, neurochemistry, clinical pharmacology, genetics, clinical trials, and experimental therapeutics. This edition features many new full-color images, additional coverage of pediatric disorders, updated Parkinson information, and many other valuable updates. An accompanying Expert Consult website makes the content fully searchable and contains several hundred video clips that illustrate the manifestations of all the movement disorders in the book along with their differential diagnoses. Get just the information you need for a clinical approach to diagnosis and management, with minimal emphasis on basic science. Find the answers you need quickly and easily thanks to a reader-friendly full-color format, with plentiful diagrams, photographs, and tables. Apply the latest advances to diagnosis and treatment of pediatric movement disorders, Parkinson disease, and much more. View the characteristic presentation of each disorder with a complete collection of professional-quality, narrated videos online. Better visualize every concept with new full-color illustrations throughout. Search the complete text online, follow links to PubMed abstracts, and download all of the illustrations, at www.expertconsult.com. |
| what medications require aims assessment: A Guide to the Extrapyramidal Side Effects of Antipsychotic Drugs D. G. Cunningham Owens, 1999-03-11 A very readable and well illustrated 1999 clinical guide to the common side effects of antipsychotic medication. |
| what medications require aims assessment: Crossing the Quality Chasm Institute of Medicine, Committee on Quality of Health Care in America, 2001-07-19 Second in a series of publications from the Institute of Medicine's Quality of Health Care in America project Today's health care providers have more research findings and more technology available to them than ever before. Yet recent reports have raised serious doubts about the quality of health care in America. Crossing the Quality Chasm makes an urgent call for fundamental change to close the quality gap. This book recommends a sweeping redesign of the American health care system and provides overarching principles for specific direction for policymakers, health care leaders, clinicians, regulators, purchasers, and others. In this comprehensive volume the committee offers: A set of performance expectations for the 21st century health care system. A set of 10 new rules to guide patient-clinician relationships. A suggested organizing framework to better align the incentives inherent in payment and accountability with improvements in quality. Key steps to promote evidence-based practice and strengthen clinical information systems. Analyzing health care organizations as complex systems, Crossing the Quality Chasm also documents the causes of the quality gap, identifies current practices that impede quality care, and explores how systems approaches can be used to implement change. |
| what medications require aims assessment: Psychiatry of Intellectual Disability Julie P. Gentile, Paulette Marie Gillig, 2012-03-22 Patients with intellectual disability (ID) can benefit from the full range of mental health services. To ensure that psychiatric assessment, diagnosis and treatment interventions are relevant and effective; individuals with ID should be evaluated and treated within the context of their developmental framework. Behavior should be viewed as a form of communication. Individuals with ID often present with behavioral symptoms complicated by limited expressive language skills and undiagnosed medical conditions. Many training programs do not include focused study of individuals with ID, despite the fact that patients with ID will be seen by virtually every mental health practitioner. In this book, the authors present a framework for competent assessment and treatment of psychiatric disorders in individuals with ID. Psychiatry of Intellectual Disability is a resource guide for psychiatrists, nurse practitioners, and other prescribers treating patients with ID. It is a supplemental text for psychiatry residents, medical students, psychology graduate students, psychotherapists, counselors, social workers, behavior support specialists and nurses. To assist the practicing clinician the book includes: Clinical vignettes Clinical pearls Charts for quick reference Issues concerning medications and poly-pharmacy Altered diagnostic criteria specific for use with individuals with ID There are no evidence-based principles dedicated to psychotropic medication use in ID, but consensus guidelines address the high prevalence of poly-pharmacy. Altered diagnostic criteria have been published which accommodate less self-report and incorporate collateral information; this book reviews the literature on psychotropic medications, consensus guidelines, and population-specific diagnostic criteria sets. Psychiatry of Intellectual Disability also includes: Interviewing techniques and assessment tips for all levels of communicative ability as well as for nonverbal individuals Assessment of aggression to determine etiology and formulate a treatment plan Overview of types of psychotherapy and suggested alterations for each to increase efficacy Relevant legal issues for caregivers and treatment providers The detective work involved in mental health assessment of individuals with ID is challenging yet rewarding. The highest quality mental health treatment limits hospital days, improves quality of life and often allows individuals to live in the least restrictive environments. Psychiatry of Intellectual Disability is a must have resource for clinicians treating the ID population. |
| what medications require aims assessment: Catastrophic Withdrawal Kathleen A Shea, 2020-12-02 While Kathleen A. Shea is best known for starting the first national nonprofit organization for tardive dyskinesia, TD is only part of her story. Be ready to be shocked by Kathleen's account of her cataclysmic attempt at Seroquel(R) withdrawal and how it altered her life forever. From the physician who told her to taper off her 14-year experience with Seroquel (quetiapine) in less than 14 days, to the holistic drug withdrawal clinic where she spent almost three months and left much worse than when she arrived, no one seemed to realize they were tapering her at too rapid a pace for her brain chemistry to maintain equilibrium. Though she was on Seroquel for insomnia, and rebound insomnia is the most well-known effect of Seroquel withdrawal, what Kathleen experienced was beyond the wildest imagination of any Seroquel patient and most psychiatric physicians. |
| what medications require aims assessment: Psychotropic Drug Information Handbook Matthew A. Fuller, Martha Sajatovic, 2005 |
| what medications require aims assessment: Manual of Clinical Psychopharmacology Alan F. Schatzberg, Jonathan O. Cole, 1991 Discussing the use of various types of drugs in the treatment of psychiatric patients, this volume covers such topics as anti-depressants, mood stabilizers, hypnotics and anti-psychotics drugs. It also looks at combination treatments and pharmacotherapy of chemical dependence. |
| what medications require aims assessment: The Common Marmoset in Captivity and Biomedical Research Robert P. Marini, Lynn M. Wachtman, Suzette D. Tardif, Keith Mansfield, James G. Fox, 2018-11-19 The Common Marmoset in Captivity and Biomedical Research is the first text dedicated exclusively to this species,filling an urgent need for an encyclopedic compilation of the existing information. Sponsored by the AmericanCollege of Laboratory Animal Medicine as part of its authoritative Blue Book series, the book covers the biology,management, diseases, and clinical and research applications of this important species. The common marmoset(Callithrix jacchus) has come of age in the scientific community as a behaviorally complex, cognitively advanced,small, prolific, and easily maintained nonhuman primate with many of the advantages of larger animals, such asmacaques, but without the attendant physical and zoonotic risks. Marmosets are currently being used in diverse areas of inquiry, including vision and auditory research, infectious disease, cognitive neuroscience, behavior, reproductive biology, toxicology and drug development, and aging. Themarmoset genome has been sequenced and there is currently an intensive effort to apply gene editing technologies to the species. The creation of transgenic marmosets will provide researchers with a small nonhuman primatemodel to study a number of poorly understood disorders, like autism. - Presents a complete view of the marmoset, covering their biology and management, diseases and clinical applications, and research applications - Includes contributions from renowned and international authors and editors - Provides the first authoritative and comprehensive treatment of marmosets in biomedical research as part of the ACLAM Series |
| what medications require aims assessment: How to Develop and Implement a National Drug Policy World Health Organization, 2001 A drug policy is a crucial ingredient in every country's national health strategy as it provides a strategic framework to identify goals and commitments. This publication discusses the key components of such a policy. Issues covered include: the selection of essential drugs, affordability; finance and supply; regulation and quality assurance; rational use; research; human resources; monitoring and evaluation. |
| what medications require aims assessment: Motivational Enhancement Therapy Manual , 1992 |
| what medications require aims assessment: American Psychiatric Association Practice Guidelines American Psychiatric Association, 1996 The aim of the American Psychiatric Association Practice Guideline series is to improve patient care. Guidelines provide a comprehensive synthesis of all available information relevant to the clinical topic. Practice guidelines can be vehicles for educating psychiatrists, other medical and mental health professionals, and the general public about appropriate and inappropriate treatments. The series also will identify those areas in which critical information is lacking and in which research could be expected to improve clinical decisions. The Practice Guidelines are also designed to help those charged with overseeing the utilization and reimbursement of psychiatric services to develop more scientifically based and clinically sensitive criteria. |
| what medications require aims assessment: Age-Friendly Health Systems Terry Fulmer, Leslie Pelton, Jinghan Zhang, 2022-02 According to the US Census Bureau, the US population aged 65+ years is expected to nearly double over the next 30 years, from 43.1 million in 2012 to an estimated 83.7 million in 2050. These demographic advances, however extraordinary, have left our health systems behind as they struggle to reliably provide evidence-based practice to every older adult at every care interaction. Age-Friendly Health Systems is an initiative of The John A. Hartford Foundation and the Institute for Healthcare Improvement (IHI), in partnership with the American Hospital Association (AHA) and the Catholic Health Association of the United States (CHA), designed Age-Friendly Health Systems to meet this challenge head on. Age-Friendly Health Systems aim to: Follow an essential set of evidence-based practices; Cause no harm; and Align with What Matters to the older adult and their family caregivers. |
| what medications require aims assessment: Canadian Study of Health and Aging Christina Wolfson, 2002 This supplement to the journal, International Psychogeriatrics introduces the Canadian Study of Health and Aging, one of the largest epidemiologic studies of dementia conducted to date. A comprehensive description of the study methods and data sets as well as selected results are discussed. |
| what medications require aims assessment: Postoperative Pain Management F. Michael Ferrante, Timothy R. VadeBoncouer, 1993 |
| what medications require aims assessment: CRPS Peter R. Wilson, Michael d'A. Stanton-Hicks, R. Norman Harden, 2005 Complex regional pain syndrome is a medically and economically significant condition that is disproportionate to the inciting event. Until now, it has been difficult to make the diagnosis, but this volume presents validated diagnostic criteria for the condition. Treatment for the condition has been hampered by the lack of good clinical evidence. This volume summarizes all reported treatments and evaluates the scientific evidence for each. A treatment algorithm is presented. This is a text that will be invaluable for the clinician, and for all those who address the issues of CRPS in the medical, rehabilitation, public health, or medicolegal fields. |
| what medications require aims assessment: Inclusion Works! Faye Ong, 2009 |
IMPLEMENTATION OF ABNORMAL INVOLUNTARY MOVEMENT SCALE (AIMS…
•A 90% increase in AIMS assessment documentation in patients’ EMR. METHODOLOGY (PROJECT PLAN) ... • Kumsa, A., Girma, S., Alemu, B., & Agenagnew, L. (2020). Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia. Clinical pharmacology: advances and applications, 12, 179 ...
Tardive Dyskinesia: Spotlight on Current Approaches to Treatment
voluntary Movement Scale (AIMS), which allows providers to track a patient’s symptoms over time and determine the appropriate course of action. The AIMS is a 12-item scale; items 1–7 measure involuntary movements across regions, scoredona scaleranging from0 (nodyskinesia)to 4(severe dyskinesia), resulting in a maximum score of 28 (5). Items
HEALTH & SAFETY: PSYCHIATRIC MEDICATIONS - IN.gov
team assessment, decision-making, or medical advice. This is the second of ten Fact Sheets regarding psychotropic medications. Intended Outcomes Individuals will understand why typical antipsychotics are prescribed, how they work, the range and severity of side effects, how the physician monitors these medicines, and the actions needed to support
Comprehensive Geriatric Assessment Toolkit for Primary Care …
Physical assessment 7 Functional, social and environmental assessment 10 Psychological components 13 Medication review 15 3 Creating a problem list 17 4 Care and support planning 20 5 Involving Social Services 24 Section 2 – Specific Presentations 26 1 Patients presenting with mobility and balance issues 26 2 Bone health 31
Cheat Sheet on Medicare Payments for Behavioral Health ... - AIMS …
4 Apr 2019 · • Initial assessment, including administration of validated scales and resulting in a treatment plan; • Review by psychiatric consultant and modifications, if recommended; • Entering patients into a registry and tracking patient follow-up and progress, and participation in weekly caseload review with psychiatric consultant; and
Improving Clinician Adherence Rates to AIMS Testing on …
Of the 53 charts reviewed pre implementation, 62% had an AIMS screening, whereas post implementation 72% has an AIMS screening showing a 10% increase. Of those screened pre implementation, 6% had a positive AIMS scores compared to the 0% recorded post implementation. Discussion: The increase in AIMS screenings helped to identify early …
Swallowing safety of oral liquid medications: assessment using …
the variability in the formulation of liquid medications, some inherent difference amongst them in terms of their thickness is likely. Additionally, some liquid medications can be stored at room temperature, whilst others require refrigeration. Temperature can have a significant effect on viscosity. For example, refrigeration resulted in a
Center for Clinical Standards and Quality/Survey & Certification …
increased blood pressure. Types of medications that may produce anticholinergic side effects include: o Antihistamines, antidepressants, antipsychotics, antiemetics, muscle relaxants; and o Certain medications used to treat cardiovascular conditions, Parkinson’s disease, urinary incontinence, gastrointestinal issues and vertigo.
Standards for student supervision and assessment - The Nursing …
Assessment of students and confirmation of proficiency (sections 6 to 10) In these standards we set out what we require from educators who are assessing and confirming students’ practice and academic achievement. We describe the role and responsibilities of the practice assessor and the academic assessor.
SELF-ADMINISTRATION OF MEDICINES (SAM) BY PATIENTS
7.2 Appropriate information should be given to the patient during the assessment process to enable them to make an informed decision whether to undertake self-administration following assessment of capacity. 7.3 The key points to be communicated include: • aims of self administration and the reason this individual has been chosen as suitable
THE AMERICAN PSYCHIATRIC ASSOCIATION PRACTICE …
2 . M.D., Chair), liaisons from the APA Assembly for their input and assistance, and APA Councils and others for providing feedback during the comment period.
Guideline on Safe Use of High Alert Medications (HAMs) - PKD …
CATEGORIES OF HIGH ALERT MEDICATIONS All medications categorized in Table 1 are examples categories of High Alert Medications (HAMs) although it may not be listed individually in this guideline. The healthcare facilities should review the list and identify their own individual list of HAMs. Table 1: Categories of High Alert Medications 1.
MANAGEMENT OF ACUTE ALCOHOL WITHDRAWAL - NICE
1 Ealing For assistance with complex alcohol problems, refer to the Alcohol Nurse Specialist / Alcohol Care Team Northwick Pk/ Central Middx: Adrian Brown 07984699707, or Liaison Psychiatry 020 8515 5010
Recognition and Management of Antipsychotic-induced …
resolution of dyskinesia may occur.6 If tardive dyskinesia is suspected, the 12-item Abnormal Involuntary Movement Scale (AIMS) is the accepted standard to confirm diagnosis and to facilitate ongoing assessment.10 Risk factors: first-generation antipsychotic medications are higher risk than second-generation agents, and risk increases with higher
What’s Next for Tardive Dyskinesia? Expert Insights from a
I will do an AIMS assessment every once in a while I use my own assessments Clinical response matters more than any assessment AIMS is great but it is not the only thing to consider If there is a combination of TD and parkinsonism, I need to find out what bothers the patient most and treat it accordingly Ask the patient (or caregiver) questions:
Comprehensive Nursing Assessment - FormsPal
Probably can make higher level decisions (such as whether to undergo or withdraw life sustaining treatments that require understanding the nature, probable consequences, burdens and risks of proposed treatment). Probably can make limited decisions that require simple understanding, able to direct own health care, including delegated tasks.
‘When Required’ (PRN) Medication - Guidance for Care homes
advice of a healthcare professional (usually to treat a minor ailment, which does not require a prescription). There are many exceptions to self-care, including treatment of a long-term condition. Certain self-care medications may be needed for PRN use (e.g. lozenges for a sore throat) – in
Curriculum Requirement for Intravenous Administration of Medications ...
used for intravenous administration of medications within 12 weeks (3 months). To be demonstrated by competency assessment/verification by nursing supervisors. RNs have successfully completed the course upon meeting all assessment criterion (80% for theory assessment & 100% for both simulated and clinical competency assessment) and with
Type 2 diabetes in adults: management - NICE
• diet and lifestyle advice • checking your blood pressure at least once a year • checking your blood glucose • testing your HbA1c levels (which reflect your average blood glucose level over the past
The Royal College of Emergency Medicine Best Practice Guideline
o Early Assessment o Assessment and diagnosis o Continuing and ongoing care ... of patient care above all other aims for the NHS ”. This document should be read in conjunction with the following RCEM documents: Quality in Emergency Care: Defining and measuring the quality of care in EDs ... This will require active planning for patients who ...
Long-Term Care Facility Resident Assessment Instrument 3.0 …
the assessment, and should be validated for accuracy (what the resident’s actual status was during that observation period) by the IDT completing the assessment. As such, nursing homes are responsible for ensuring that all participants in the assessment process have the requisite knowledge to complete an accurate assessment.
UPDATE ON THE USE OF PSYCHOTROPIC AGENTS IN …
28 Nov 2019 · • Use of these medications must comply with all applicable clinical and regulatory guidelines • evisions to CMS requirementsR * and the State Operations Manual † provide important guidance relevant to the use of antipsychotic agents for the treatment of hallucinations and delusions associated with PDP *
Cheat Sheet on Medicare Payments for Behavioral Health ... - AIMS …
4 Apr 2019 · • Initial assessment, including administration of validated scales and resulting in a treatment plan; • Review by psychiatric consultant and modifications, if recommended; • Entering patients into a registry and tracking patient follow-up and progress, and participation in weekly caseload review with psychiatric consultant; and
THE AIMS AND OBJECTIVES OF ENVIRONMENTAL IMPACT ASSESSMENT …
If plans are based on a sound environmental assessment, speci fic project proposals which fail to conform are likely to require detailed environmental assessment. The preparation of plans must be based on adequate data relating to the existing environment and the implications of possible changes. The systematic collection,
Preoperative Management of Gastrointestinal and Pulmonary Medications ...
PULMONARY MEDICATIONS Recommendations for the preoperative management of pulmonary medications are summarized in Table 1. Anticholinergic Medications These inhaled medications work by blocking the ability of acetylcholine to bind to musca-rinic receptors, in turn inhibiting bronchial constriction and mucus production. Specific
Ravenswood School Medications Policy
Medications Policy \\dc01\Winpool$\Policies & Procedures\Approved Policies\Policies 2022-2023\2023-03\Medications Policy 2023.docx 1 of 4 Rationale Many of our pupils will need to take medication at some time during their school life. Administering medication to pupils will minimise the time they have off school. Aims:
PSYCHOTROPIC MEDICATION GUIDELINES - Riverside …
and not prescribe medications utilized for other medical treatment purposes. To obtain these medications, clients must be seen by a primary care provider or other specialist. Medi-Cal funding for psychotropic medications is carved out of the state’s Medi-Cal funding. Psychotropic medications prescribed by RCDMH providers are generally billed
Perceived Competencies of BSHM Students of AIMS Toward the …
NCII holders in Housekeeping and Food and Beverage Services were first awarded to AIMS in 2016. It was supported by the Wilijado P. Abuid (WPA) Foundation, an affiliate foundation of AIMS and a TESDA-accredited assessment facility. In 2019, the NCII in Front Office Services was examined satisfactorily.
PSYCHOTROPIC MEDICATION PRESCRIBING GUIDELINES: …
Ongoing GDR assessment & documentation: • At admission or within 2 weeks: At the time of the initial. MDS assessment on. new admissions who do not require PASRR screening. • During quarterly care plan meeting if not more. often. • When identified as possibly causing or. contributing to an adverse consequence or change in condition.
1 DRAFT ASHP Guidelines on Medication-Use Evaluation
DRAFT ASHP Guidelines on Medication-Use Evaluation 5 88 solely through a committee having oversight for MUE (e.g., pharmacy and therapeutics [P&T] 89 committee). Typical follow-up actions based on MUE findings include information-sharing and 90 education (e.g., newsletters, seminars, clinical care guidelines) and changes to existing policies, 91 but some MUEs may …
Assessment of Competence for Registered Healthcare …
Contact e learning if you require the video for training purposes. ASSESSMENT: Using performance criteria below RISK ASSESSMENT: HIGH (level of risk of harm due to user error) UPDATE: Competence to be reviewed annually and a record maintained within ward / department and within individuals personal file. UNDERPINNING KNOWLEDGE
Swallowing safety of oral liquid medications: assessment using …
the variability in the formulation of liquid medications, some inherent difference amongst them in terms of their thickness is likely. Additionally, some liquid medications can be stored at room temperature, whilst others require refrigeration. Temperature can have a significant effect on viscosity. For example, refrigeration resulted in a
ASHP Guidelines on Medication-Use Evaluation
Prioritizing medications and medication-use processes for evaluation The indicators described above may reveal specific medications or medication-use processes that should be evaluated in an MUE. The following partial list of characteristics may help prioritize the selection of a particular medication or medication-use process,
Controlled drugs: safe use and management - NICE
1.3 Risk assessment for organisations. 1.3 Risk assessment for organisations. 1.4 Processes for reporting controlled drug‑related incidents. 1.4 Processes for reporting controlled drug‑related incidents. 1.5 Prescribing controlled drugs. 1.5 Prescribing controlled drugs. 1.6 Obtaining and supplying controlled drugs
Medicines in health and adult social care - Care Quality Commission
of our assessment of the safe key question looks at how services manage medicines. Reducing harm from medicines is a key national and international priority, and both the Department of Health and Social Care and the World Health Organization (WHO) have committed to this. This report aligns with both initiatives and provides additional context for
Medication Safety in Long-Term Care - ISMP Canada
of a medication safety self-assessment program. In response to widespread interest in improving systems and processes to enhance medication safety, ISMP Canada has developed a series of Medication Safety Self-Assessment® (MSSA) programs for a variety of settings. The MSSA for Long Term Care 1 is a comprehensive survey directed toward
ABNORMAL INVOLUNTARY MOVEMENT SCALE (AIMS)
AIMS EXAMINATION PROCEDURE Either before or after completing the Examination Procedure observe the patient unobstrusively at rest (e.g., in waiting room). The chair to be used in this examination should be a hard, firm one without arms. * * * Title: Microsoft Word - …
Neuropsychological Assessment in Memory Services Guidance …
assessment can successfully differentiate between specific dementia subtypes, as well as delineating dementia from normal ageing, MCI or mental health conditions, such as depression4,5. Neuropsychological assessment and formulation can help in the following ways: • To inform diagnosis and treatment planning.
Managing medicines for adults receiving social care in the …
Assess a person's medicines support needs as part of the overall assessment of their needs and preferences for care and treatment. 1.2.2 . Do not take responsibility for managing a person's medicines unless the overall assessment indicates the need to do so, and this has been agreed as part of local governance arrangements. 1.2.3
Evidence-based guideline: Treatment of tardive syndromes
medications (including dose reduction and cessation), non-neuroleptic compounds that affect the dopamine and noradrenaline systems, vitamin B 6,andvitaminE. The preferred outcome measures are objective clinical ratingscalesofTDSseverity(e.g.,AbnormalInvoluntary Movement Scale [AIMS]).15 Two panelists reviewed
ANTENATAL CARE SERVICES - World Health Organization
- Detecting conditions that require additional care and providing appropriate treatment for those conditions ... etc.) and the infant (assessment of its condition, maintaining body temperature, initiating breastfeeding, etc.) take place. There is a smooth transition between childbirth and the postpartum period. ... The aims of care in the ...
Telehealth for Assessing and Managing Tardive Dyskinesia: …
Despite the availability of approved TD medications (e.g., vesicular monoamine transporter 2 [VMAT2] inhibitors, valbenazine and deutetrabenazine), identification, diagnosis, and assessment of this disorder remains complex, and these complexities can be compounded when care is delivered via telehealth.22 Further education regarding appropriate
What is Physiological Measurement? - BSCN
used here means assessment of function of major organ systems. No less than the more familiar tests that are part of normal clinical care, physiological measures are integral to the processes of diagnosis and therapeutic intervention, and to the experience of millions of patients. It is time to give closer attention to
Intravenous fluid therapy in adults in hospital - NICE
preferences. This discussion aims to help them to reach a fully informed decision (see also ‘Patient-centred care’). Interventions that must (or must not) be used We usually use ‘must’ or ‘must not’ only if there is a legal duty to apply the recommendation. Occasionally we use ‘must’ (or ‘must not’) if the
Unique Identifier: Version Number: Self Administration o f …
ensure any changes to the patient’s medications are clearly communicated to the patient, and contribute to the on-going assessment of the patient for suitability to self-administer medicines. Further details of the prescriber’s roles can be found in Appendix 1. 2.7 Medication Errors
State of Connecticut Department of Developmental Services
Self-Medication Assessment: An assessment of the individual’s ability to independently self-administer medications or to assist with medication administration shall be completed on admission to the residence and updated annually or when there is a change in condition which may interfere with the individual’s ability to self-
Medication Management in Intellectual Disability Settings: A …
further developed to find application in the complexity and uniqueness of intellectual disability settings. In such settings, medication management and administration may take place across
Assessment of the Role of Pharmacists in Preventing
assessment also aims to determine the effectiveness of pharmacist-led interventions in reducing medication errors, such as medication reconciliation, medication
GDL08 Guideline for the management of In-patients with …
Initial Equality Impact Assessment: Completed Yes Full Equality Impact assessment (as required): Completed NA . If you require this document in an alternative format e.g., larger print please contact Policy Administrator 8904 for Trust- wide documents or your line manager or Divisional Management office for Local documents. Contact for Review
Dementia: assessment, management and support for people …
20 Jun 2018 · It aims to improve care by making recommendations on training staff and helping carers to support people living with dementia. NICE has also produced a guideline on mid-life approaches to delay or prevent the onset of dementia. Who is it for? • Healthcare and social care professionals caring for and supporting people living with dementia
